Subcutaneous injection of neutralizing anti-CCL27 antibody to AD mice with early skin lesions can alleviate the clinical progression of inflammation with reduced infiltration of T cells and mast cells in the skin and down-regulation of inflammatory cytokines (69). Here, CCL27 is linked to Alzheimer disease.